Five pharma cybersecurity breaches to know and learn from
The transition to digital, expedited by the Covid-19 pandemic, has opened up new cybersecurity concerns.
Technology
Billionaires are betting on anti-ageing research, but can ageing really be cured?
Amazon founder Jeff Bezos has reportedly invested in Altos Labs, a new anti-ageing start-up that...
Sanofi concludes acquisition of Translate Bio for $3.2bn
Sanofi expects the deal to be vital for its mRNA Center of Excellence to unravel...
Everest and Providence to advance Covid-19 vaccines in Asia markets
Providence will receive an upfront payment of $50m in cash from Everest on licencing its...
Ferring draws closer to a microbiome breakthrough
Ferring and subsidiary Rebiotix are developing a microbiota-based live biotherapeutic, RBX2660, against recurrent C. diff.
Algae proteins and optogenetics: a vision of the future
The vision of a completely blind man has been partially restored using light-sensing proteins found in algae.
Lödige new LC light series for cost-efficient coating
Lödige Process Technology provides high-quality machines, systems and services, customised upon request, for process technology applications in the pharmaceutical industry.
Leading regenerative medicine advocacy group leverages GlobalData’s datasets to highlight a record year
The Alliance for Regenerative Medicine’s report reveals the data behind a “year of firsts and records” for the sector.
Moderna submits preliminary data to FDA for Covid-19 booster shot
The company also intends to seek approval for the third dose in Europe and other regions.
Innovent and Bolt to create three antibody conjugates for cancer
Bolt will receive $5m as upfront payment and up to $10m as potential equity investment from Innovent.
Why Covid-19 didn’t hurt tech brands’ appetite for Asian investment
Companies have reason to be sceptical about investing in Asia in general and in China in particular. But Asia investment could still be a good bet, writes Giacomo Lee.
